Nrd Ra Treatment[2] Ppt $2$ $1$
-
Upload
krishna-moorthy-mottupalli -
Category
Documents
-
view
158 -
download
0
Transcript of Nrd Ra Treatment[2] Ppt $2$ $1$
![Page 1: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/1.jpg)
EXPLORING THE REGULATION OF NRD-CONVERTASE EXPRESSION BY RETINOIC ACID
KRISHNA MOORTHYSUPERVISOR: DR. ADRIAN PIEROTTI
![Page 2: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/2.jpg)
INTRODUCTION
• NRD-CONVERTASE (NRDc) is a cytosolic and cell-surface metallopeptidase enzyme.
• It is classified under Clan ME in Family M16, Subfamily A, M16.005 (merops).
• This enzyme is present in abundant amount in endocrine tissues, in rat testis at late stages of spermatogenesis and brain cortex.
![Page 3: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/3.jpg)
INTRODUCTION CONTINUED….
• The 90 amino acid acidic domain inserted close to NRDc active site differentiates it from other members of the M16 family of metalloendopeptidases.
• NRDc acts by cleaving arginine residues on N-terminus of basic amino acid or lysine in basic pairs.
![Page 4: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/4.jpg)
IMPORTANCE OF ENZYME
• Role in Alzheimer Disease, Brain Diseases, Down Syndrome, Leukemia Neoplasms and Neuroblastoma
![Page 5: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/5.jpg)
PREVIOUS STUDIES:• Draoui M et al (1997): When treated with retinoic
acid for 2 days, SK-N-BE(2) cell lines showed an increase in the expression of NRD Convertase in the cytoplasm.
• BE(2)-NA cell lines showed 9-fold increase in the expression of NRD Convertase within few hours to a day treatment.
• Interestingly, NRD Convertase expression was down regulated in BE(2)-M(17) cells after 5 days treatment of Retinoic acid.
![Page 6: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/6.jpg)
• The authors used immunochemistry and northern blotting to do this study.
• Real time-PCR is used in this study to get more accurate results.
![Page 7: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/7.jpg)
OBJECTIVES:
• To investigate the possible modulation of NRD-convertase expression in the presence of Retinoic acid (1 µM, 5 µM), Tamibarotene (1 µM) at different time points.
![Page 8: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/8.jpg)
METHODS
![Page 9: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/9.jpg)
Figure 1. Samples of SK-N-BE cells of Actin and NRDc on gel electrophoresis
![Page 10: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/10.jpg)
![Page 11: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/11.jpg)
Figure 2. Restriction digest of Actin and NRDc on gel electrophoresis
![Page 12: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/12.jpg)
STD OF ACTINConc Log
[conc]Actin Only (Ct values)
Average
10pg 7 12.29 13.52 12.91
100fg 5 19.59 18.83 19.21
1fg 3 25.43 25.72 25.58
10ag 1 29.17 30.14 29.66
CONCENTRATION OF ACTIN
![Page 13: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/13.jpg)
STD OF NRDConc Log [ag] NRD only
(Ct values)Average
10pg 7 13.23 13.49 13.36
100fg 5 19.46 20.51 19.99
1fg 3 27.08 25.95 26.52
10ag 1 30.56 29.68 30.12
CONCENTRATION OF NRD
![Page 14: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/14.jpg)
ACTIN IN COMBO WITH NRDlog [ag] Actin+NRD Actin only
1 33.51 32.05
3 28.91 28.04
5 22.7 21.75
7 16.69 17.05
CONCENTRATION OF ACTIN
![Page 15: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/15.jpg)
NRD in comboLog[ag] NRD only NRD + ACTIN
1 32.23 32.4
3 28.89
5 21.75 22.74
7 16.01 16.71
CONCENTRATION OF NRD
![Page 16: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/16.jpg)
CELL TISSUE CULTURE• TREATMENTS 1µM TAMBIROTENE 1µM RETINOIC ACID 5µM RETINOIC ACID
• TIMES 6 HOURS 24 HOURS 48 HOURS
• MEASURE Ct NRD Ct ACT in same tube Calculate ∆Ct = CtNRD-CtACT Calculate ∆∆Ct = ∆CtControl-∆CtTreatment ∆∆Ct = 1 = 2 fold change
![Page 17: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/17.jpg)
∆∆Ct of NRDc level
∆∆Ct for
Treatment 6 hrs treatment 24 hrs treatment 48 hrs treatment
Retinoic acid 1µM 0.537333 -0.395 -0.335
Retinoic acid 5µM 0.401667 -0.238333333 -0.56166667
Tamibarotene 1µM 0.3425 -0.708333333 -0.155
control 0 0 0
![Page 18: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/18.jpg)
FOLD CHANGE OF NRDc LEVEL AFTER DRUG TREATMENT
FOLD CHANGE OF NRDc LEVEL AFTER
![Page 19: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/19.jpg)
BAR CHART REPRESENTATION OF FOLD CHANGE OF NRDc LEVEL
![Page 20: Nrd Ra Treatment[2] Ppt $2$ $1$](https://reader033.fdocuments.in/reader033/viewer/2022051122/5884a0ce1a28ab26058b74b9/html5/thumbnails/20.jpg)
Conclusion:
• As presence of retinoic acid causes changes in expression of NRD levels in human SK B NE cells, it can be concluded that retinoic acid plays an important role in pathogenesis of brain diseases.
• The results is not similar with previous works. This may be due to small number of samples treated. To get more accurate result this experiment must be repeated with more number of treatment.